130 related articles for article (PubMed ID: 12533831)
1. Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma.
Tanaka Y; Kato K; Notohara K; Nakatani Y; Miyake T; Ijiri R; Nishimata S; Ishida Y; Kigasawa H; Ohama Y; Tsukayama C; Kobayashi Y; Horie H
J Pathol; 2003 Feb; 199(2):185-90. PubMed ID: 12533831
[TBL] [Abstract][Full Text] [Related]
2. Abnormal beta-catenin expression in oral cancer with no gene mutation: correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features.
Odajima T; Sasaki Y; Tanaka N; Kato-Mori Y; Asanuma H; Ikeda T; Satoh M; Hiratsuka H; Tokino T; Sawada N
Hum Pathol; 2005 Mar; 36(3):234-41. PubMed ID: 15791567
[TBL] [Abstract][Full Text] [Related]
3. Significance of beta-catenin and pRB pathway components in malignant ovarian germ cell tumours: INK4A promoter CpG island methylation is associated with cell proliferation.
Kawauchi S; Liu XP; Kawasaki K; Hirakawa T; Amada S; Furuya T; Oga A; Sasaki K
J Pathol; 2004 Nov; 204(3):268-76. PubMed ID: 15476271
[TBL] [Abstract][Full Text] [Related]
4. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
[TBL] [Abstract][Full Text] [Related]
5. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin nuclear accumulation in head and neck mucoepidermoid carcinoma: its role in cyclin D1 overexpression and tumor progression.
Shiratsuchi H; Nakashima T; Hirakawa N; Toh S; Nakagawa T; Saito T; Tsuneyoshi M; Komune S
Head Neck; 2007 Jun; 29(6):577-84. PubMed ID: 17315172
[TBL] [Abstract][Full Text] [Related]
7. Frequent deletions and mutations of the beta-catenin gene are associated with overexpression of cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma.
Takayasu H; Horie H; Hiyama E; Matsunaga T; Hayashi Y; Watanabe Y; Suita S; Kaneko M; Sasaki F; Hashizume K; Ozaki T; Furuuchi K; Tada M; Ohnuma N; Nakagawara A
Clin Cancer Res; 2001 Apr; 7(4):901-8. PubMed ID: 11309340
[TBL] [Abstract][Full Text] [Related]
8. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm.
Tanaka Y; Kato K; Notohara K; Hojo H; Ijiri R; Miyake T; Nagahara N; Sasaki F; Kitagawa N; Nakatani Y; Kobayashi Y
Cancer Res; 2001 Dec; 61(23):8401-4. PubMed ID: 11731417
[TBL] [Abstract][Full Text] [Related]
9. Cribriform-morular variant of papillary thyroid carcinoma: a pathological and molecular genetic study with evidence of frequent somatic mutations in exon 3 of the beta-catenin gene.
Xu B; Yoshimoto K; Miyauchi A; Kuma S; Mizusawa N; Hirokawa M; Sano T
J Pathol; 2003 Jan; 199(1):58-67. PubMed ID: 12474227
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin accumulation in the progression of human hepatocarcinogenesis correlates with loss of E-cadherin and accumulation of p53, but not with expression of conventional WNT-1 target genes.
Prange W; Breuhahn K; Fischer F; Zilkens C; Pietsch T; Petmecky K; Eilers R; Dienes HP; Schirmacher P
J Pathol; 2003 Oct; 201(2):250-9. PubMed ID: 14517842
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 overexpression in thyroid papillary microcarcinoma: its association with tumour size and aberrant beta-catenin expression.
Lantsov D; Meirmanov S; Nakashima M; Kondo H; Saenko V; Naruke Y; Namba H; Ito M; Abrosimov A; Lushnikov E; Sekine I; Yamashita Sh
Histopathology; 2005 Sep; 47(3):248-56. PubMed ID: 16115225
[TBL] [Abstract][Full Text] [Related]
12. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
Ueta T; Ikeguchi M; Hirooka Y; Kaibara N; Terada T
Oncol Rep; 2002; 9(6):1197-203. PubMed ID: 12375019
[TBL] [Abstract][Full Text] [Related]
13. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
[TBL] [Abstract][Full Text] [Related]
14. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma.
Kato K; Nakatani Y; Kanno H; Inayama Y; Ijiri R; Nagahara N; Miyake T; Tanaka M; Ito Y; Aida N; Tachibana K; Sekido K; Tanaka Y
J Pathol; 2004 Jul; 203(3):814-21. PubMed ID: 15221941
[TBL] [Abstract][Full Text] [Related]
15. Nuclear beta-catenin correlates with cyclin D1 expression in spindle and pleomorphic sarcomas but not in synovial sarcoma.
Saito T; Oda Y; Yamamoto H; Kawaguchi K; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2006 Jun; 37(6):689-97. PubMed ID: 16733209
[TBL] [Abstract][Full Text] [Related]
16. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
[TBL] [Abstract][Full Text] [Related]
18. Cadherins, catenins and APC in pleural malignant mesothelioma.
Abutaily AS; Collins JE; Roche WR
J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
[TBL] [Abstract][Full Text] [Related]
19. Nuclear translocation of beta-catenin in colorectal cancer.
Kobayashi M; Honma T; Matsuda Y; Suzuki Y; Narisawa R; Ajioka Y; Asakura H
Br J Cancer; 2000 May; 82(10):1689-93. PubMed ID: 10817505
[TBL] [Abstract][Full Text] [Related]
20. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]